Archana Ramireddy
Clinical Cardiac Electrophysiology · Los Angeles, CANPI 1538434964
Payments from drug & device makers
Across 212 payments — averaging $187.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$19K
- Abbott$12K
- Medtronic$7K
- Biosense Webster, Inc.$787
- Cook Medical LLC$223
- AstraZeneca$124
- plus $96 from 2 others
What the payments were for
- Consulting fees$2,8507%
- Speaking & faculty fees$13,63834%
- Travel & lodging$10,73027%
- Food & beverage$12,06730%
- Education$4251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 58 | $19,134 |
| Abbott | 72 | $12,275 |
| Medtronic(2 entities) | 67 | $7,069 |
| Biosense Webster, Inc. | 7 | $787 |
| Cook Medical LLC | 4 | $223 |
| AstraZeneca | 1 | $124 |
| Stereotaxis Inc | 2 | $66 |
| Cordis US CORP. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Farapulse$14,557
- ENDURITY$2,138
- GENERAL EP$1,875
- AVEIR$1,840
- ENSITE$1,719
- ENSITE PRECISION$1,613
- GALLANT$1,175
- GENERAL BRADY$1,048
- DURATA$800
- EVERA MRI XT DR SURESCAN$605
- Carto 3$541
- TENDRIL$500
- MERLIN@HOME$375
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$340
- GENERAL - THERAPIES$267
- COBALT DR MRI SURESCAN$263
- AFFERA MAPPING SYSTEM$166
- Evolution$165
- EnSite Precision Cardiac Mapping System$133
- EnSite X$131
How this compares
$39,709 in reported general payments places this provider in the 50th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 96 | $80,910 |
| XareltoRivaroxaban | 21 | $19,034 |
| MultaqDronedarone Hcl | 12 | $6,959 |
| Amiodarone Hcl | 39 | $1,992 |
| Flecainide Acetate | 18 | $449 |
| SotalolSotalol Hcl | 42 | $448 |
| Metoprolol Succinate | 41 | $427 |
| Metoprolol Tartrate | 11 | $88 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Los Angeles
- Rahul DoshiLos Angeles$2M
- Leslie SaxonLos Angeles$1.2M
- Nigel GuptaLos Angeles$1.1M
- Koonlawee NademaneeLos Angeles$835K
- Ivan HoLos Angeles$455K
- Olujimi AjijolaLos Angeles$342K
- Eric BuchLos Angeles$236K
- Marmar VaseghiLos Angeles$201K
- David KrummenSan Diego$7.3M
- Jonathan DukesVentura$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.